E-LIB Suche - Ergebnisse für: Karpecki, Paul

1

The impact of Demodex blepharitis on patient symptoms and d..:

Barnett, Melissa ; Simmons, Blake ; Vollmer, Patrick...
Optometry and Vision Science. 101 (2024) 3 - p. 151-156 , 2024

Link: https://doi.org/10.1097/..

2

Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochlorid..:

Holland, Edward ; Karpecki, Paul ; Fingeret, Murray...
Clinical Therapeutics. 46 (2024) 2 - p. 104-113 , 2024

Link: https://doi.org/10.1016/..

3

Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis:

Gaddie, Ian Benjamin ; Donnenfeld, Eric D. ; Karpecki, Paul...
Ophthalmology. 130 (2023) 10 - p. 1015-1023 , 2023

Link: https://doi.org/10.1016/..

4

Demodex Blepharitis: A Comprehensive Review of the Disease,..:

Rhee, Michelle K. ; Yeu, Elizabeth ; Barnett, Melissa...
Eye & Contact Lens: Science & Clinical Practice. 49 (2023) 8 - p. 311-318 , 2023

Link: https://doi.org/10.1097/..

5

Real-world treatment patterns of OTX-101 ophthalmic solutio..:

Karpecki, Paul ; Barghout, Victoria ; Schenkel, Brad...
BMC Ophthalmology. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

The Prevalence of Demodex Blepharitis in US Eye Care Clinic..:

Trattler, William ; Karpecki, Paul ; Rapoport, Yuna...
Clinical Ophthalmology. 16 (2022) - p. 1153-1164 , 2022

Link: https://doi.org/10.2147/..

7

Reduction of Artificial Tears and Use of Adjunctive Dry Eye..:

Nichols, Kelly K ; Donnenfeld, Eric D ; Lau, Charis...
Clinical Ophthalmology. 16 (2022) - p. 909-916 , 2022

Link: https://doi.org/10.2147/..

8

Therapeutic Potential of "Derived-Multiple Allogeneic Prote..:

Harrell, Carl Randall ; Fellabaum, Crissy ; Miloradovic, Dragica...
Serbian Journal of Experimental and Clinical Research. 23 (2022) 2 - p. 167-173 , 2022

Link: https://doi.org/10.2478/..

9

Interpersonal Communication in Eye Care: An Analysis of Pot..:

Hellem, Amy ; LaBelle, Sara ; Matossian, Cynthia.
Clinical Ophthalmology. 16 (2022) - p. 1003-1008 , 2022

Link: https://doi.org/10.2147/..

10

Selective Pharmacologic Therapies for Dry Eye Disease Treat..:

Shen Lee, Bridgitte ; Toyos, Melissa ; Karpecki, Paul..
Ophthalmology and Therapy. 11 (2022) 4 - p. 1333-1369 , 2022

Link: https://doi.org/10.1007/..

11

Safety and efficacy of lotilaner ophthalmic solution, 0.25%..:

Gonzalez-Salinas, Roberto ; Karpecki, Paul ; Yeu, Elizabeth...
Contact Lens and Anterior Eye. 45 (2022) 4 - p. 101492 , 2022

Link: https://doi.org/10.1016/..

12

Reproxalap Improves Signs and Symptoms of Allergic Conjunct..:

Clark, David ; Karpecki, Paul ; Salapatek, Anne Marie..
Clinical Ophthalmology. 16 (2022) - p. 15-23 , 2022

Link: https://doi.org/10.2147/..

13

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety ..:

Sheppard, John ; Bergmann, Mark ; Schechter, Barry A...
Clinical Ophthalmology. 15 (2021) - p. 129-140 , 2021

Link: https://doi.org/10.2147/..

14

Clinically Relevant Activity of the Novel RASP Inhibitor Re..:

Clark, David ; Cavanagh, Bill ; Shields, Alan L....
American Journal of Ophthalmology. 230 (2021) - p. 60-67 , 2021

Link: https://doi.org/10.1016/..

15

A Post-Acute Ocular Tolerability Comparison of Topical Repr..:

McMullin, David ; Clark, David ; Cavanagh, Bill..
Clinical Ophthalmology. 15 (2021) - p. 3889-3900 , 2021

Link: https://doi.org/10.2147/..